生物工艺用袋及容器市场－全球产业规模、份额、趋势、机会、预测：按应用、产品类型、最终用户、地区和竞争格局划分，2021-2031年

全球生物工艺袋和容器市场预计将从 2025 年的 37.6 亿美元大幅成长至 2031 年的 81.1 亿美元，复合年增长率为 13.67%。

这些一次性或半耐用容器专为生物製药工作流程中无菌液体的安全处理和运输而设计，与传统的不銹钢容器相比，其显着优势在于无需清洗验证，并可缩短生产前置作业时间。推动这一成长的主要因素是全球对生物製药和疫苗日益增长的需求，这需要灵活且扩充性的生产能力。正如欧洲製药工业协会联合会 (EFPIA) 在 2024 年指出的那样，欧洲以研发为导向的製药业在研发方面的投资约为 550 亿欧元，这清楚地表明，大量资本投资正支持依赖这些流体管理解决方案的开发平臺。

儘管前景乐观，但一次性耗材产生的塑胶废弃物在环境永续性方面仍面临许多挑战。随着产量增加以满足全球医疗保健需求，该行业面临着如何管理这些容器中使用的复杂多层聚合物薄膜的处置和回收这一艰鉅任务。如果没有有效的循环经济策略，该行业可能会面临严格的监管和不断上涨的处置成本，最终阻碍一次性生物製程系统的长期应用。

市场驱动因素

随着製造商将成本效益和营运柔软性置于优先地位，向一次性生物製程技术的快速转型正在从根本上重塑市场格局。以一次性袋和容器取代传统的不锈钢基础设施，无需复杂的就地清洗(CIP) 和原位蒸气灭菌 (SIP) 系统，从而降低了资本投资。这种转变缩短了设施的运作週期，并最大限度地降低了交叉污染的风险，这对于寻求运作的多产品生产设施至关重要。这种对弹性技术的投入也体现在重大资本计划中。例如，富士胶片迪奥辛斯生物技术公司 (Fujifilm Diosynth Biotechnologies) 于 2024 年 4 月宣布追加 12 亿美元投资，用于扩展其大规模细胞培养网络，从而直接增强其依赖一次性容器的灵活生产方法。

此外，全球对生物製药和生物相似药日益增长的需求，正成为推动流体管理耗材需求成长的重要外部因素。随着业界从小分子药物转向大分子疗法，从上游工程到下游製程中安全、扩充性且无菌的流体处理变得愈发重要。监理核准也印证了这个趋势。美国食品药物管理局（FDA）于2024年1月发布的《2023年新药核准报告》列出了17项新的生物製药核准申请，凸显了需要特殊防护技术的复杂疗法的核准进程。为了满足这项需求，三星生物製剂等合作伙伴公司正在扩大营运规模，预计2024年年营收将达到3.69兆韩元。这一数字与生物製程容器使用量的成长相吻合。

市场挑战

一次性耗材产生的塑胶废弃物的环境永续性是限制全球生物工艺袋和容器市场成长的主要障碍。随着生物製药生产的扩张，不可回收的多层聚合物废弃物的累积给製造商带来了巨大的财务和合规责任。这项挑战直接限制了市场扩张，因为旨在实现永续性目标的公司可能会减少一次性系统的使用，以降低因环境影响增加而带来的声誉风险和监管处罚。因此，与废弃物管理相关的复杂物流成本增加，推高了总拥有成本 (TCO)，这可能会抵消通常推动这些技术应用的效率提升。

生物製程系统联盟 (Bio-Process Systems Alliance) 2024 年发布的产业数据显示，预计到 2028 年，生物製药生产相关的塑胶废弃物将达到每年约 11,700 公吨。日益增长的废弃物数量给现有的废弃物管理基础设施带来了沉重负担。随着日益严格的环境法规即将出台，目前生物污染薄膜回收效率低下，迫使製造商必须采用成本高昂的焚化或专门的掩埋处理方式。这种经济负担限制了市场发展，阻碍了在註重成本的生产环境中，传统不銹钢设备转向一次性替代品的转变。

市场趋势

一个显着的趋势是细胞和基因治疗 (CGT) 工作流程中越来越多地使用生物袋。这与传统生物製药以大规模生产为中心的模式形成鲜明对比。与在大型生物反应器中生产的单株抗体不同，自体和异体移植疗法需要小型、封闭的二维和三维生物製程容器来处理患者特异性批次，并确保低温储存和运输过程中的安全。这项要求促使製造商创新专用薄膜技术，以在超低温环境下保持高价值、小批量产品的无菌性和完整性。再生医学联盟 (Alliance for Regenerative Medicine) 于 2025 年 1 月发布的《产业趋势简报》重点强调了这一领域的成长，该简报指出，该领域的投资成长了 30%，表明依赖这些先进的隔离解决方案的强劲产品线扩张势头。

同时，一次性解决方案正显着扩展至下游工艺，其应用范围已从基本的缓衝液储存扩展到复杂的纯化、填充和表面处理工程。传统上，一次性袋用于上游工程正在推动层析法、病毒灭活和最终製剂製程中一次性组件的应用。这种转变最大限度地减少了操作空间，并消除了与不銹钢管道相关的清洁验证瓶颈。领先的製药公司正在检验向整合式一次性生产线的转型；例如，诺华公司于2025年4月宣布，将在五年内投资230亿美元，用于构建端到端生产能力，其中包括siRNA技术，该技术在下游製程中高度依赖一次性流体通道。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球生物工艺用袋与容器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域（上游工程、下游製程、製程开发、其他）
  • 产品类型（二维生物製程袋/容器、三维生物製程袋/容器）
  • 按最终用户（製药和生物製药公司、学术和研究机构、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美生物製程用袋与容器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲生物工艺用袋和容器的市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区生物製程用袋和容器的市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物工艺用袋和容器的市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲生物工艺用袋与容器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球生物工艺用袋与容器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Meissner Filtration Products, Inc.
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Saint-Gobain
• Corning Incorporated
• Entegris
• PROAnalytics, LLC
• CellBios Healthcare and Lifesciences Pvt Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Bioprocess Bags & Containers Market is projected to expand significantly, rising from USD 3.76 Billion in 2025 to USD 8.11 Billion by 2031, representing a compound annual growth rate of 13.67%. These disposable or semi-durable vessels are designed for the safe handling and transport of sterile fluids within biopharmaceutical workflows, offering a distinct advantage over traditional stainless steel options by eliminating cleaning validation needs and shortening production turnaround times. A key factor driving this growth is the intense global demand for biologics and vaccines, which requires adaptable and scalable manufacturing capabilities. As noted by the European Federation of Pharmaceutical Industries and Associations in 2024, the research-based pharmaceutical sector invested approximately 55,000 million euros in R&D across Europe, highlighting the massive capital supporting development pipelines that depend on these fluid management solutions.

Despite this positive outlook, the market encounters a substantial obstacle regarding the environmental sustainability of plastic waste produced by disposable consumables. As production volumes increase to address global health demands, the industry faces the difficult task of managing the disposal and recycling of the complex multi-layer polymer films utilized in these containers. If effective circular economy strategies are not adopted, the sector may face stringent regulatory measures and rising disposal costs, which could ultimately hinder the widespread long-term adoption of disposable bioprocessing systems.

Market Driver

The rapid shift toward single-use bioprocessing technologies is fundamentally reshaping the market as manufacturers prioritize cost efficiency and operational flexibility. By replacing traditional stainless steel infrastructure, single-use bags and containers reduce capital expenditures by eliminating the need for elaborate clean-in-place and steam-in-place systems. This transition enables faster facility turnover and minimizes cross-contamination risks, a crucial benefit for multiproduct facilities seeking to maximize operational uptime. This commitment to flexible technology is reflected in major capital projects, such as Fujifilm Diosynth Biotechnologies' April 2024 announcement of an additional 1.2 billion USD investment to expand its large-scale cell culture network, directly bolstering flexible production methods reliant on disposable containment.

Additionally, the escalating global demand for biologics and biosimilars acts as a pivotal external force driving the volume of fluid management consumables. As the industry moves from small-molecule drugs to large-molecule therapies, the necessity for secure, scalable, and sterile liquid handling throughout upstream and downstream processes has intensified. Regulatory approvals underscore this trend; the U.S. Food and Drug Administration's 'New Drug Therapy Approvals 2023' report, released in January 2024, noted the approval of 17 new biologics license applications, emphasizing the commercialization of complex therapeutics requiring specialized containment. To accommodate this demand, partners like Samsung Biologics are scaling operations, reporting 3.69 trillion KRW in annual revenue in 2024, a figure that correlates with the heightened usage of bioprocess containers.

Market Challenge

The environmental sustainability of plastic waste from disposable consumables represents a major barrier to the growth of the Global Bioprocess Bags & Containers Market. As biopharmaceutical production scales, the accumulation of non-recyclable, multi-layer polymer waste generates significant financial and compliance liabilities for manufacturers. This challenge directly restricts market expansion because companies aiming to meet corporate sustainability goals may curtail their use of single-use systems to mitigate reputational risks and regulatory penalties linked to an increased environmental footprint. Consequently, the complicated logistics involved in managing end-of-life disposables increase the total cost of ownership, potentially negating the efficiency gains that usually encourage the adoption of these technologies.

Industry data provided by the Bio-Process Systems Alliance in 2024 indicates that plastic waste related to biopharmaceutical manufacturing is expected to reach nearly 11,700 metric tons annually by 2028. This growing volume exerts tremendous strain on existing waste management infrastructures. With strict environmental mandates approaching, the current inability to effectively recycle these bio-contaminated films compels manufacturers to rely on expensive incineration or specialized landfilling options. This financial strain acts as a restraint on the market, deterring the transition from traditional stainless steel equipment to disposable alternatives in cost-sensitive manufacturing environments.

Market Trends

A significant trend is the increasing use of bags in cell and gene therapy (CGT) workflows, which diverges from the volume-centric demands of traditional biologics. In contrast to monoclonal antibodies produced in large-scale bioreactors, autologous and allogeneic therapies require smaller, closed-system 2D and 3D bioprocess containers to handle patient-specific batches and ensure safety during cryogenic storage and transport. This requirement compels manufacturers to innovate specialized film technologies that retain integrity at ultra-low temperatures while preserving sterility for high-value, low-volume products. The growth in this area is highlighted by the Alliance for Regenerative Medicine's January 2025 'State of the Industry Briefing', which reported a 30 percent increase in sector investment, indicating strong pipeline expansion dependent on these advanced containment solutions.

Simultaneously, the market is witnessing a significant expansion of single-use solutions into downstream processing, extending beyond basic buffer storage to include complex purification and fill-finish tasks. While disposable bags were traditionally used for upstream media preparation, the push for end-to-end continuous manufacturing is fostering the adoption of single-use assemblies for chromatography, viral inactivation, and final formulation. This shift minimizes the operational footprint and removes cleaning validation bottlenecks associated with stainless steel piping. Major pharmaceutical companies are validating this move toward integrated disposable lines; for instance, Novartis announced in April 2025 a 23 billion USD investment over five years to build end-to-end manufacturing capabilities, including siRNA technologies that rely heavily on downstream single-use fluid pathways.

Key Market Players

• Meissner Filtration Products, Inc.
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Saint-Gobain
• Corning Incorporated
• Entegris
• PROAnalytics, LLC
• CellBios Healthcare and Lifesciences Pvt Ltd.

Report Scope

In this report, the Global Bioprocess Bags & Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioprocess Bags & Containers Market, By Application

• Upstream Processes
• Downstream Processes
• Process Development
• Others

Bioprocess Bags & Containers Market, By Product Type

• 2D Bioprocess Bags and Containers
• 3D Bioprocess Bags
• Containers

Bioprocess Bags & Containers Market, By End User

• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Others

Bioprocess Bags & Containers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Bags & Containers Market.

Available Customizations:

Global Bioprocess Bags & Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Bags & Containers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Upstream Processes, Downstream Processes, Process Development, Others)
  • 5.2.2. By Product Type (2D Bioprocess Bags and Containers, 3D Bioprocess Bags, Containers)
  • 5.2.3. By End User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Bioprocess Bags & Containers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Product Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioprocess Bags & Containers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bioprocess Bags & Containers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bioprocess Bags & Containers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By End User

7. Europe Bioprocess Bags & Containers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Product Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bioprocess Bags & Containers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Bioprocess Bags & Containers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bioprocess Bags & Containers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bioprocess Bags & Containers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bioprocess Bags & Containers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Bioprocess Bags & Containers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Product Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bioprocess Bags & Containers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bioprocess Bags & Containers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bioprocess Bags & Containers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bioprocess Bags & Containers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bioprocess Bags & Containers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Bioprocess Bags & Containers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Product Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bioprocess Bags & Containers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Bioprocess Bags & Containers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Bioprocess Bags & Containers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By End User

10. South America Bioprocess Bags & Containers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Product Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bioprocess Bags & Containers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Bioprocess Bags & Containers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Bioprocess Bags & Containers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bioprocess Bags & Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Meissner Filtration Products, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Sartorius AG
• 15.4. Danaher Corporation
• 15.5. Merck KGaA
• 15.6. Saint-Gobain
• 15.7. Corning Incorporated
• 15.8. Entegris
• 15.9. PROAnalytics, LLC
• 15.10. CellBios Healthcare and Lifesciences Pvt Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer